Robert DeSantis - 25 Jan 2022 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
26 Jan 2022, 11:00:30 UTC
Prior SEC filing
26 Oct 2021
Next SEC filing
16 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Donna Spinola For: Robert DeSantis

Key filing fact

Robert DeSantis filed Form 4 for INTUITIVE SURGICAL INC (ISRG) on 26 Jan 2022.

Key facts

  • This page summarizes Robert DeSantis's Form 4 filing for INTUITIVE SURGICAL INC (ISRG).
  • 12 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 26 Jan 2022, 11:00.

Change

  • Previous filing in this sequence was filed on 26 Oct 2021.
  • Current net transaction value: -$59,556.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ISRG transaction

Common Stock

Options Exercise

Transaction value
$146,623
Shares
+597
Change %
+55%
Price
$245.60
Shares after
1,689
Date
25 Jan 2022
Ownership
Direct
Footnotes
F1
ISRG transaction

Common Stock

Sale

Transaction value
$156,199
Shares
-597
Change %
-35%
Price
$261.64
Shares after
1,092
Date
25 Jan 2022
Ownership
Direct
Footnotes
F1
ISRG transaction

Common Stock

Options Exercise

Transaction value
$66,158
Shares
+273
Change %
+25%
Price
$242.34
Shares after
1,365
Date
25 Jan 2022
Ownership
Direct
Footnotes
F1
ISRG transaction

Common Stock

Sale

Transaction value
$71,428
Shares
-273
Change %
-20%
Price
$261.64
Shares after
1,092
Date
25 Jan 2022
Ownership
Direct
Footnotes
F1
ISRG transaction

Common Stock

Options Exercise

Transaction value
$48,519
Shares
+270
Change %
+25%
Price
$179.70
Shares after
1,362
Date
25 Jan 2022
Ownership
Direct
Footnotes
F1
ISRG transaction

Common Stock

Sale

Transaction value
$70,643
Shares
-270
Change %
-20%
Price
$261.64
Shares after
1,092
Date
25 Jan 2022
Ownership
Direct
Footnotes
F1
ISRG transaction

Common Stock

Options Exercise

Transaction value
$48,056
Shares
+270
Change %
+25%
Price
$177.99
Shares after
1,362
Date
25 Jan 2022
Ownership
Direct
Footnotes
F1
ISRG transaction

Common Stock

Sale

Transaction value
$70,643
Shares
-270
Change %
-20%
Price
$261.64
Shares after
1,092
Date
25 Jan 2022
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ISRG transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-270
Change %
-10%
Price
$0.000000
Shares after
2,358
Date
25 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
270
Exercise price
$177.99
Footnotes
F1, F2
ISRG transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-270
Change %
-8.8%
Price
$0.000000
Shares after
2,808
Date
25 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
270
Exercise price
$179.70
Footnotes
F1, F3
ISRG transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-273
Change %
-10%
Price
$0.000000
Shares after
2,352
Date
25 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
273
Exercise price
$242.34
Footnotes
F1, F4
ISRG transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-597
Change %
-7.6%
Price
$0.000000
Shares after
7,272
Date
25 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
597
Exercise price
$245.60
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.

Footnote F2

Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Footnote F3

Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time.

Footnote F4

Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .